Maryna Arkhypova

Maryna Arkhypova

Auto-generated profile, based on publicly available information

Maryna Arkhypova

SI “L. V. Hromashevsky Institute of Epidemiology and Infectious Diseases of the NAMS of Ukraine

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 December 2021 in Innovative Biosystems and Bioengineering
Verified
Journal Article
Open access
PDF file
ODOleksandra Dmytrenko
Oleksandra Dmytrenko
MAMaryna Arkhypova
Maryna Arkhypova
DSDarya Starosyla
Darya Starosyla
SRSvitlana Rybalko
Svitlana Rybalko
MGMichael Gevorkyan
Michael Gevorkyan
AGAlexander Galkin
Alexander Galkin
Background. Programs of preclinical safety studies of the health care products depend on the regulatory status of the investigated products. The classification of such products, in particular suppositories for rectal and vaginal use, is a critical step of developing tactics for their biological evaluation. Adaptation of biological evaluation methods for the medical devices based on the combination of biologically active substances, as well as evaluation of the results of such studies is urgent task of biomedicine. Objective. To substantiate the regulatory status and to carry out a biological evaluation of medical devices in the form of vaginal suppositories based on octenidine dihydrochloride ("Prodexyn") and in the form of rectal suppositories based on Saw palmetto, Levisticum officinale and Calendula officinalis extracts ("Pravenor"). Methods. Biological evaluation was conducted according to the requirements of ISO 10993 standards using in vitro and in vivo biological test systems (cytotoxicity in cell culture and the MTT test, sensitizing and irritating effect in guinea pigs). Results. The cytotoxicity (СС50) of the medical device "Prodexyn" extract in Vero cell culture was 8.35 μg/ml calculated as octenidine dihydrochloride and 416.65 μg/ml calculated as dexpanthenol. "Pravenor" medical device was found to be non-toxic in Vero cell culture. According to the results of MMT assay CC50 for octenidine dihydrochloride was 1.67 μg/ml, and 83.33 μg/ml – for dexpanthenol. CC50 indicators calculated for the different active ingredients of the medical device "Pravenor" were the following: 50 mg/ml for the dwarf palm berries extract (Saw palmetto), 16.67 mg/ml for the lovage roots extract (Levisticum officinale), and 16.67 mg/ml for the calendula flowers extract (Calendula officinalis). No sensitizing or skin irritating effects were observed in guinea pigs. Conclusions. Biological evaluation of medical devices in the form of rectal suppositories "Pravenor" and vaginal suppositories "Prodexyn" performed using in vitro and in vivo biological systems. It was demonstrated an acceptable level of safety of the products. The MTT test was 5 times more sensitive than the Vero cell culture method in determination of cytotoxicity.

12 November 2023 in Innovative Biosystems and Bioengineering
Verified
Journal Article
Open access
PDF file
MAMaryna Arkhypova
Maryna Arkhypova
ODOleg Deriabin
Oleg Deriabin
TTTetiana Trokhymchuk
Tetiana Trokhymchuk
DSDaria Starosyla
Daria Starosyla
VAViktor Atamaniuk
Viktor Atamaniuk
AGAlexander Galkin
Alexander Galkin
Background. Viral infections trigger transcription factors, including Nrf2, which regulate the expression of genes related to cytokines, chemokines, and more. Nuclear factor erythroid 2-related factor 2 (Nrf2) participates in complex regulatory networks controlling the expression of cytoprotective genes and immune responses. Recently, new roles have been attributed to Nrf2, including the regulation of antiviral responses. Objective. The aim of the study was to analyze Nrf2 activation in influenza virus infection in vivo and in transmissible gastroenteritis coronavirus (TGEV) infection in vitro, as well as the effects of the flavonoid compositions Proteflazidum® and Protoil on the Nrf2 expression in these two experimental models of viral infection. Methods. Outbred white mice were infected with influenza A virus (A/FM/1/47/H1N1 strain). Jurkat cells were infected with TGEV, previously adapted to these cells. Flavonoid compositions Proteflazidum® and Protoil (Ecopharm, Ukraine), containing the mixture of tricin, luteolin, apigenin, quercetin, and rhamnosin, were used in corresponding dilutions. Real-Time PCR was employed to analyze Nrf2 RNA expression in the lungs of mice and in both uninfected and virus-infected cells. Additionally, ELISA was used to assess the expression of Nrf2 peptide. Results. The Nrf2 expression in the lungs of influenza virus-infected mice showed a tendency to increase within a 100-fold range. In virus-infected mice treated with Proteflazidum® or Protoil, the level of Nrf2 expression in the lungs decreased about 10-fold compared to infected untreated mice. TGEV infection resulted in 100-fold increase in Nrf2 expression in Jurkat cells. Both Proteflazidum® and Protoil decreased Nrf2 expression in TGEV-infected cells, while their effects on Nrf2 expression in the intact cells on Day 1 were not detected. Conclusions. Flavonoid compositions have only a slight effect on Nrf2 expression in intact cells. However, in case of virus infection, both in vivo and in vitro, they counteract the extensive up-regulation of Nrf2 expression due to viral infection.

15 December 2024 in Preventive medicine. Theory and practice
Verified
Journal Article
Closed access
MAM.A. Arkhypova
M.A. Arkhypova
DSD. B. Starosyla
D. B. Starosyla
TTT. Yu. Trokhymchuk
T. Yu. Trokhymchuk
YPYu. I. Porva
Yu. I. Porva
LCLlc Ukrainian Medical And Diagnostic Center
Llc Ukrainian Medical And Diagnostic Center
LELlc “Nvk Ekopharm
Llc “Nvk Ekopharm
The review highlights the current state of research on enteroviruses, in particular polioviruses, ECHO viruses, Coxsackie, and enterovirus type 71, which cause a significant number of human infectious diseases. The main aspects of their replication, pathogenesis, and molecular biological properties are discussed. Particular attention is paid to the prospects for the use of flavonoids as antiviral agents. The mechanisms of their action are analyzed, including the inhibition of proteases and blocking the interaction of viral components with cellular targets. The cytotoxicity and antiviral efficacy of a number of flavonoid compounds in model systems are considered. The review emphasizes the importance of searching for new natural substances and synthetic derivatives for the development of therapeutic agents against enterovirus infections, given the limitations of existing treatment options and the peculiarities of the mutagenicity of these viruses.

1 October 2026 in Preventive medicine. Theory and practice
Verified
Journal Article
Closed access
OVO. Vasylchenko
O. Vasylchenko
TTT. Trokhymchuk
T. Trokhymchuk
MAM. Arkhypova
M. Arkhypova
DSD. Starosyla
D. Starosyla
SHS. Hryhorieva
S. Hryhorieva
ODO. Deriabin
O. Deriabin
Summary. Targeted protein degradation (TPD) is a modern strategy for developing new therapeutic agents that requires not only detection of decreased target abundance but also stepwise validation of the compound’s mechanism of action. In this approach, the disappearance of the target protein is necessary but insufficient, because it does not by itself distinguish proteasomal degradation from inhibition of protein synthesis, loss of antibody epitope, toxicity, or altered protein solubility. Therefore, degrader analysis should rely on a hierarchy of methods that sequentially assess target protein abundance, selectivity and kinetics, compound binding to the target or E3 ligase, ternary complex formation, ubiquitination, and dependence of target loss on proteasomal clearance. This article summarizes methods used in degrader development and groups them by the measured parameter, type of experimental response, and mechanistic information provided by each method. Objective: to define a hierarchy of methods used to study protein degraders and to show which stage of the mechanism of action is assessed by each group of methods. Conclusions. Rational development of protein degraders cannot rely solely on the observed decrease in target protein abundance. Quantitative, biophysical, cellular, structural, and causal assays should be combined to confirm compound binding, formation of a productive E3-ligase complex, target ubiquitination, and proteasomedependent degradation. This stepwise evidentiary framework reduces the risk of false interpretation and supports more rational optimization of molecules. Keywords: targeted protein degradation, ternary complex, luminescence, fluorescence.

1 January 2023 in Preventive medicine. Theory and practice
Verified
Journal Article
Closed access
MAM.A. Arkhypova
M.A. Arkhypova
NINational Technical University of Ukraine “Igor Sikorsky Kyiv Polytechnic Institute”
National Technical University of Ukraine “Igor Sikorsky Kyiv Polytechnic Institute”
EZE.M. Zherebtsova
E.M. Zherebtsova
VAV.P. Atamanyuk
V.P. Atamanyuk
SUSI "L.V. Gromashevsky Institute of Epidemiology and Infectious Diseases of NAMS of Ukraine”
SI "L.V. Gromashevsky Institute of Epidemiology and Infectious Diseases of NAMS of Ukraine”
K“Kyiv Llc “Rpc “Ecopharm”
Kyiv Llc “Rpc “Ecopharm”